These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6163720)

  • 1. Elicitation of natural killer cells in beige mice by infection with vesicular stomatitis virus.
    McKinnon KP; Hale AH; Ruebush MJ
    Infect Immun; 1981 Apr; 32(1):204-10. PubMed ID: 6163720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental vesicular stomatitis virus infection of swine: extent of infection and immunological response.
    Redelman D; Nichol S; Klieforth R; Van Der Maaten M; Whetstone C
    Vet Immunol Immunopathol; 1989 Mar; 20(4):345-61. PubMed ID: 2470190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
    Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
    J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
    Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
    J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
    Bowman MR; Lyles DS; Parce JW
    J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
    Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
    J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
    [No Abstract]   [Full Text] [Related]  

  • 8. Differing responses of hamsters to infection by vesicular stomatitis virus Indiana and New Jersey serotypes.
    Fultz PN; Holland JJ
    Virus Res; 1985 Sep; 3(2):129-40. PubMed ID: 2414943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets.
    Kamiyama T
    Infect Immun; 1984 Mar; 43(3):973-80. PubMed ID: 6199309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
    Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
    Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity to vesicular stomatitis virus infections in mice.
    Zinkernagel RM; Adler B; Holland JJ
    Exp Cell Biol; 1978; 46(1-2):53-70. PubMed ID: 202522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.
    Fultz PN; Shadduck JA; Kang CY; Streilein JW
    Infect Immun; 1982 Aug; 37(2):679-86. PubMed ID: 6180986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
    Ciavarra R; Forman J
    J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal molecular and cellular requirements for elicitation of secondary anti-vesicular stomatitis virus cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ
    J Immunol; 1980 Oct; 125(4):1569-77. PubMed ID: 6251135
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of delayed-type hypersensitivity by vesicular stomatitis virus infection in mice.
    Katsura Y; Takaoki M; Kono Y; Minato N
    J Immunol; 1980 Oct; 125(4):1459-62. PubMed ID: 6157735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis by natural killer cells requires viral replication and glycoprotein expression.
    Schattner A; Rager-Zisman B
    Immunol Lett; 1986 Oct; 13(5):261-8. PubMed ID: 3021619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection.
    Maloy KJ; Odermatt B; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1160-5. PubMed ID: 9448302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.